Norgesic Should Be Avoided in 65-Year-Old Patients
Norgesic (orphenadrine + aspirin) should not be prescribed to a 65-year-old patient due to its classification as a potentially inappropriate medication in older adults. The orphenadrine component is explicitly listed in the 2019 American Geriatrics Society Beers Criteria as a muscle relaxant to avoid in older adults 1.
Why Orphenadrine Is Problematic in Older Adults
The Beers Criteria specifically identifies orphenadrine as inappropriate for older adults due to:
- Strong anticholinergic effects causing CNS toxicity, sedation, and delirium risk
- Poor tolerability compared to safer alternatives
- Questionable effectiveness for muscle relaxation in this age group 1
The FDA label confirms that elderly patients may experience mental confusion with orphenadrine, and these anticholinergic effects are dose-dependent 2. The 2022 European Society of Cardiology guidelines on polypharmacy reinforce using tools like the Beers Criteria to identify potentially inappropriate medications in older adults 3.
The Aspirin Component Adds Additional Concerns
The aspirin in Norgesic (770 mg per dose in Norgesic Forte) presents further risks:
- High-dose aspirin (>325 mg/day) is flagged in the Beers Criteria as increasing gastrointestinal bleeding risk 1
- NSAIDs including aspirin show significantly higher rates of upper GI symptoms in elderly users (28% vs 16.6% in non-users) 4
- The combination provides anti-inflammatory salicylate levels 5, but at doses that substantially increase bleeding risk in older adults
Efficacy Data Does Not Support Use
Recent evidence demonstrates that skeletal muscle relaxants, including orphenadrine, provide no benefit over placebo when combined with NSAIDs for acute low back pain. In a 2022 analysis, orphenadrine showed mean RMDQ improvement of 9.5 vs 10.5 for placebo (not statistically significant), with results consistent across all age groups 6.
Specific Contraindications to Screen For
Before prescribing Norgesic to any patient, the FDA label mandates checking for absolute contraindications 7:
- Glaucoma
- Prostatic hypertrophy or bladder neck obstruction (common in older men)
- Myasthenia gravis
- Peptic ulcer disease
- Coagulation abnormalities
The anticholinergic effects can worsen urinary retention, particularly problematic in older men with benign prostatic hyperplasia 2.
What to Prescribe Instead
For musculoskeletal pain in a 65-year-old:
- Acetaminophen as first-line (safer analgesic profile)
- Topical NSAIDs if localized pain (reduced systemic exposure)
- Physical therapy and non-pharmacologic approaches
- If oral NSAIDs needed, use lowest effective dose for shortest duration with gastroprotection
The evidence clearly demonstrates that adding a muscle relaxant like orphenadrine provides no additional benefit over analgesics alone 6, while substantially increasing adverse effect risk in older adults 1.